moxifloxacin has been researched along with mirabegron in 2 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (mirabegron) | Trials (mirabegron) | Recent Studies (post-2010) (mirabegron) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 558 | 131 | 538 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
de Koning, P; Goldwater, R; Kaibara, A; Keirns, JJ; Kowalski, DL; Lee, JH; Malik, M; Moy, SS; Mujais, SK; Schaddelee, MP; van Gelderen, EM; Yen, M | 1 |
Bonate, PL | 1 |
1 trial(s) available for moxifloxacin and mirabegron
Article | Year |
---|---|
Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study.
Topics: Acetanilides; Adolescent; Adrenergic beta-Agonists; Adult; Anti-Infective Agents; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Quinolines; Sex Characteristics; Thiazoles; Urinary Bladder, Overactive; Young Adult | 2012 |
1 other study(ies) available for moxifloxacin and mirabegron
Article | Year |
---|---|
The application of extreme value theory to pharmacometrics.
Topics: Acetanilides; Cross-Over Studies; Data Interpretation, Statistical; Datasets as Topic; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Heart Rate; Humans; Male; Minimal Clinically Important Difference; Models, Biological; Moxifloxacin; Pharmacology, Clinical; Placebos; Randomized Controlled Trials as Topic; Thiazoles | 2021 |